Conexeu Sciences Commences Trading on Nasdaq Under Ticker Symbol "CNXU"
Conexeu Sciences Inc. (CNXU) has officially commenced trading on the Nasdaq stock exchange. The company, a preclinical-stage biotechnology firm focused on regenerative tissue therapies, now has 25.3 million shares outstanding and 35.2 million shares on a fully diluted basis. Management views the public listing as a milestone that will enhance visibility and support the advancement of its proprietary CXU platform and lead product candidates, including the B.R.E.A.S.T.
Key figures
- Shares outstanding
- 25269996
- Shares fully diluted
- 35238222
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.